Embecta Corp. (EMBC) insider trading

4 insiders have bought $558k of Embecta Corp. shares across 4 disclosed dealings since August 2026. 4 of those have been scored against our six-point signal check.

Insider buys

Aug 12, 2026 Kurdikar Devdatt — President and CEO $140,937
Aug 12, 2026 Elguicze Jacob — SVP and CFO $93,360
Aug 12, 2026 Mann Jeffrey Z — Pres, Pharm Svc&Prod Mgmt, CLO $99,800
Aug 12, 2026 HOMBACH ROBERT J. — director $223,848

About Embecta Corp.

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Common questions

Where does this Embecta Corp. data come from?

Every row is a public regulatory disclosure — a Form 4 filing with the SEC — collected within minutes of being published. We don’t take company submissions and we don’t edit the numbers; the only thing we add is the rating and the reasoning behind it.

Is a insider buying shares a good signal?

Sometimes. A insider buying with their own money is one of the few honest signals in the market, but plenty of purchases are routine — small top-ups, scheme allocations, or a well-paid executive rounding out a holding. That’s what our six-point check is for: it separates the conviction buys from the housekeeping, and shows you which is which.

How often is this page updated?

The pipeline runs every 15 minutes through the trading day, so a new disclosure appears here shortly after it’s filed. Company stats refresh daily.

Can I get alerted when someone buys?

Yes — that’s what the app is for. Follow Embecta Corp. and you’ll get a push the moment a insider files, with the full analysis attached, plus alerts if the price moves after a buy you’re following.

Is this financial advice?

No. ddbx rates the conviction behind insider buys and shows the reasoning. It’s information, never a recommendation, and never a guarantee. What you do with it is your call.

Browse every company · All insider trading